Ostentus Therapeutics
$1.2Mtotal raised · 4 rounds on record
$150klatest round · Venture round · Feb 2024 · 2 yr ago
1-10team · employees, estimated range
2021founded
Overview
Bringing to people affected by cancerthe most effective and safest plant-derivedanti-cancer drugs. Email us.
Funding and backers
Total raised
$1.2M
4 rounds on record
Latest round
$150k
Venture round · Feb 2024 · 2 yr ago
Team
1-10
employees, estimated range
The money's age
Long since its last round
32 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 24, 2024
Raised a round Venture round $150k · SEC Form D
Sep 28, 2022
Raised a round Venture round $488k · SEC Form D
Jan 25, 2022
Raised a round Venture round $100k · SEC Form D
Dec 13, 2021
Raised a round Venture round $500k · SEC Form D
2021
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Feb 2024 | $150k | — | SEC Form D |
| Venture round | Sep 2022 | $488k | — | SEC Form D |
| Venture round | Jan 2022 | $100k | — | SEC Form D |
| Venture round | Dec 2021 | $500k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Ostentus Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Elisabetta GraffExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
backs Osara Health
Similar startupsby what they do, their industry and backers
Kindling Bio are putting children first with a scalable gene therapy platform for children affected by cancer.
Yemaachi is creating the world's most diverse cancer bio-database to develop the next generation of cancer drugs that are effective in…
G1 Therapeutics, Inc. is a commercial stage oncology company focused on the development and commercialization of next generation therapies…
AMO Pharma is dedicated to making a positive difference for people affected by serious and debilitating diseases, particularly rare or…
Transforming the care in cancer We empower individuals affected by cancer to thrive through clinical expertise, empathy, and human…
Targeting the Tumor Ecosystem to address cancer drug resistance and improve patients’ lives.
People
Elisabetta Graff
Executive Officer, Director
William Graff
Director
Stuart Weinstein
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
News
Report
Ostentus Therapeutics, Inc., and City of Hope to Continue Studies of Novel OST Natural Products for Treatment of Leukemia and Other Cancers
Ostentus Therapeutics, Inc., announced today that it has entered into a second Sponsored Research Agreement with City of Hope, one of the largest cancer rese...
Read more
Report
Ostentus Therapeutics, Inc., and City of Hope to Initiate Studies of Novel OST Natural Products for Treatment of Leukemia and Other Cancers
Ostentus Therapeutics, Inc., has entered into a Sponsored Research Agreement with City of Hope, a world-renowned cancer treatment and research organization a...
Read more
Report